Register      Login
Australian Journal of Chemistry Australian Journal of Chemistry Society
An international journal for chemical science

70th Birthday tribute to Professor David Craik

This collection presents papers submitted as a tribute to Professor David Craik on the occasion of his 70th birthday.

Guest Editors
Prof. Ed Nice (Monash University), Prof. Mibel Aguilar (Monash University) & Prof. John Wade (The Florey)

Last Updated: 02 Sep 2025

CH25071Proline hydroxylation and C-terminal amidation in µ-conotoxins increase structural stability and potency at sodium channels

Victoria A. Adegoke, Yashad Dongol, Tye Gonzalez, Angela Song, Richard J. Clark, Richard J. Lewis 0000-0003-3470-923X, Anne C. Conibear 0000-0002-5482-6225 and K. Johan Rosengren

Diagram showing the various structure and function assays used to study conotoxin posttranslational modifications.

Conotoxins serve as useful model peptides to understand the effects of protein posttranslational modifications (PTMs). Here, we focus on proline hydroxylation and C-terminal amidation of conotoxins PIIIA and TIIIA. Structure and function assays highlight distinct roles of these PTMs in oxidative folding, structural integrity and activity at sodium channels, advancing our understanding of PTM function in conotoxin pharmacology. (Image credit: Anne C. Conibear.)

This article belongs to the collection: 70th Birthday tribute to Professor David Craik.

CH25081Electrophilic fragment screening using native mass spectrometry to identify covalent probes for surface cysteines

Jack W. Klose 0000-0002-4084-1870, Yezhou Yu 0009-0007-9173-549X, Giovanna Di Trapani 0000-0003-2583-5832, Kathryn F. Tonissen 0000-0002-1018-2798, Louise M. Sternicki 0000-0001-6158-663X and Sally-Ann Poulsen 0000-0003-4494-3687

Schematic of surface exposed cysteine residues of carbonic anhydrase III and a spectrum of native mass spectrometry peaks.

Native mass spectrometry (nMS) was applied to screen an electrophilic covalent fragment library to identify ligands for the surface exposed cysteine residues of a soluble protein (carbonic anhydrase III), to determine which cysteines were modified and to measure the simultaneous binding of an orthosteric noncovalent inhibitor and covalent fragment hit. (Image credit: S.-A. Poulsen and L. M. Sternicki.)

This article belongs to the collection: 70th Birthday tribute to Professor David Craik.

CH25086Rational design and selection of next-generation cyclotide drugs using the knotted cyclic peptide scaffold MCoTI-II

Sven Ullrich 0000-0003-4184-7024, Grégoire Jean-Baptiste Philippe 0000-0001-8103-9211, Choi Yi Li 0000-0001-8823-3666 and Hiroaki Suga 0000-0002-5298-9186

Schematic showing the solution structure of MCoTI-II with cystine-knotted disulfide bridges highlighted.

This mini-review highlights tactics to engineer MCoTI-II, a cyclic cystine-knot peptide natural product, into next-generation therapeutics and diagnostics. Through both rational modification and genetically encoded selection platforms, variants of the MCoTI-II cyclotide have been developed for a diverse range of potential biomedical applications. (Image credit: Sven Ullrich.)

This article belongs to the collection: 70th Birthday tribute to Prof. David Craik.


Illustration of the action of a venom on MRGPRX2. The GIRK1/2 channel opens, generating a flow of inward K current.

Mast cells of our immune system are generally difficult and expensive to maintain in vitro and, therefore, not economical to use in drug discovery. The development of a bioassay expressing the human mas-related G protein-coupled receptor-X2 receptor linked to potassium channels in a host cell offers a good alternative. (Image credit: Jan Tytgat.)

This article belongs to the collection: 70th Birthday tribute to Professor David Craik.